|
G |
SLC22A5 |
solute carrier family 22 member 5 |
increases uptake |
EXP |
SLC22A5 protein results in increased uptake of Carnitine |
CTD |
PMID:16826461 |
|
NCBI chr 2:134,660,741...134,847,575
Ensembl chr 2:134,660,808...134,686,219
|
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
increases expression |
EXP |
Aluminum Oxide results in increased expression of ICAM1 protein |
CTD |
PMID:18456438 |
|
NCBI chr 2:69,097,136...69,107,722
Ensembl chr 2:69,097,122...69,108,205
|
|
G |
SELE |
selectin E |
increases expression |
EXP |
Aluminum Oxide results in increased expression of SELE mRNA; Aluminum Oxide results in increased expression of SELE protein |
CTD |
PMID:18456438 |
|
NCBI chr 4:81,289,061...81,299,657
|
|
G |
VCAM1 |
vascular cell adhesion molecule 1 |
increases expression |
EXP |
Aluminum Oxide results in increased expression of VCAM1 mRNA; Aluminum Oxide results in increased expression of VCAM1 protein |
CTD |
PMID:18456438 |
|
NCBI chr 4:117,496,914...117,511,211
Ensembl chr 4:117,496,920...117,511,222
|
|
|
G |
CD14 |
CD14 molecule |
affects expression |
EXP |
cadmium nitrate affects the expression of CD14 mRNA |
CTD |
PMID:29421334 |
|
NCBI chr 2:142,348,036...142,349,686
Ensembl chr 2:142,346,360...142,349,581
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
affects expression affects secretion |
EXP |
cadmium nitrate affects the expression of CXCL8 mRNA cadmium nitrate affects the secretion of CXCL8 protein |
CTD |
PMID:29421334 |
|
NCBI chr 8:69,932,646...69,935,861
Ensembl chr 8:69,932,643...69,935,861
|
|
G |
DEFB1 |
defensin beta 1 |
increases expression |
EXP |
cadmium nitrate results in increased expression of DEFB1 mRNA |
CTD |
PMID:29421334 |
|
|
|
G |
IFNB1 |
interferon beta 1 |
increases expression |
EXP |
cadmium nitrate results in increased expression of IFNB1 mRNA |
CTD |
PMID:29421334 |
|
NCBI chr 1:201,850,935...201,851,495
Ensembl chr 1:201,850,935...201,851,495
|
|
G |
IL18 |
interleukin 18 |
increases expression |
EXP |
cadmium nitrate results in increased expression of IL18 mRNA |
CTD |
PMID:29421334 |
|
NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,973...39,861,219
|
|
G |
IL6 |
interleukin 6 |
increases expression |
EXP |
cadmium nitrate results in increased expression of IL6 mRNA |
CTD |
PMID:29421334 |
|
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
|
|
G |
LOC110258578 |
interleukin-1 beta-like |
increases expression |
EXP |
cadmium nitrate results in increased expression of IL1B mRNA |
CTD |
PMID:29421334 |
|
|
|
G |
MAPK14 |
mitogen-activated protein kinase 14 |
affects expression |
EXP |
cadmium nitrate affects the expression of MAPK14 mRNA |
CTD |
PMID:29421334 |
|
NCBI chr 7:31,791,398...31,861,544
Ensembl chr 7:31,790,877...31,862,031
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
increases expression |
EXP |
cadmium nitrate results in increased expression of MAPK8 mRNA |
CTD |
PMID:29421334 |
|
NCBI chr14:88,988,914...89,108,875
Ensembl chr14:88,988,949...89,108,874
|
|
G |
MYD88 |
MYD88 innate immune signal transduction adaptor |
affects expression |
EXP |
cadmium nitrate affects the expression of MYD88 mRNA |
CTD |
PMID:29421334 |
|
NCBI chr13:22,976,951...22,979,568
Ensembl chr13:22,966,137...22,983,109
|
|
G |
NFKB1 |
nuclear factor kappa B subunit 1 |
affects expression |
EXP |
cadmium nitrate affects the expression of NFKB1 mRNA |
CTD |
PMID:29421334 |
|
NCBI chr 8:118,391,010...118,478,927
Ensembl chr 8:118,390,638...118,506,691
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
increases expression |
EXP |
cadmium nitrate results in increased expression of RELA mRNA |
CTD |
PMID:29421334 |
|
NCBI chr 2:6,594,869...6,602,684
Ensembl chr 2:6,593,969...6,603,469
|
|
G |
SOCS1 |
suppressor of cytokine signaling 1 |
decreases expression |
EXP |
cadmium nitrate results in decreased expression of SOCS1 mRNA |
CTD |
PMID:29421334 |
|
NCBI chr 3:31,879,143...31,883,041
Ensembl chr 3:31,881,225...31,884,967
|
|
G |
STAT3 |
signal transducer and activator of transcription 3 |
decreases expression |
EXP |
cadmium nitrate results in decreased expression of STAT3 mRNA |
CTD |
PMID:29421334 |
|
NCBI chr12:20,407,316...20,471,091
Ensembl chr12:20,407,233...20,472,992
|
|
G |
TLR4 |
toll like receptor 4 |
affects expression |
EXP |
cadmium nitrate affects the expression of TLR4 mRNA |
CTD |
PMID:29421334 |
|
NCBI chr 1:258,044,610...258,054,641
Ensembl chr 1:258,044,610...258,058,970
|
|
G |
TLR5 |
toll like receptor 5 |
increases expression |
EXP |
cadmium nitrate results in increased expression of TLR5 mRNA |
CTD |
PMID:29421334 |
|
NCBI chr10:19,387,666...19,410,024
Ensembl chr10:19,387,666...19,410,024
|
|
G |
TNF |
tumor necrosis factor |
increases expression |
EXP |
cadmium nitrate results in increased expression of TNF mRNA |
CTD |
PMID:29421334 |
|
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
|
|
|
G |
SLC22A5 |
solute carrier family 22 member 5 |
decreases activity |
EXP |
pivaloylcarnitine results in decreased activity of SLC22A5 protein |
CTD |
PMID:16826461 |
|
NCBI chr 2:134,660,741...134,847,575
Ensembl chr 2:134,660,808...134,686,219
|
|
|
G |
ADCYAP1 |
adenylate cyclase activating polypeptide 1 |
multiple interactions |
EXP |
[Carbon Dioxide co-treated with Oxygen deficiency] results in decreased expression of ADCYAP1 protein; Nicotine inhibits the reaction [[Carbon Dioxide co-treated with Oxygen deficiency] results in decreased expression of ADCYAP1 protein] |
CTD |
PMID:28506824 |
|
NCBI chr 6:105,414,628...105,422,294
Ensembl chr 6:105,414,631...105,422,294
|
|
G |
ADCYAP1R1 |
ADCYAP receptor type I |
multiple interactions |
EXP |
[Carbon Dioxide co-treated with Oxygen deficiency] results in decreased expression of ADCYAP1R1 protein |
CTD |
PMID:28506824 |
|
NCBI chr18:41,915,180...41,972,327
Ensembl chr18:41,917,428...41,972,301
|
|
G |
CHRNA2 |
cholinergic receptor nicotinic alpha 2 subunit |
multiple interactions |
EXP |
[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA2 protein; Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA2 protein] |
CTD |
PMID:28235547 |
|
NCBI chr14:11,193,732...11,204,334
Ensembl chr14:11,195,228...11,207,650
|
|
G |
CHRNA3 |
cholinergic receptor nicotinic alpha 3 subunit |
multiple interactions |
EXP |
[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA3 protein; Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA3 protein] |
CTD |
PMID:28235547 |
|
NCBI chr 7:47,361,710...47,382,743
Ensembl chr 7:47,361,899...47,384,303
|
|
G |
CHRNA7 |
cholinergic receptor nicotinic alpha 7 subunit |
multiple interactions |
EXP |
[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA7 protein; Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA7 protein] |
CTD |
PMID:28235547 |
|
NCBI chr 1:142,803,697...142,937,124
Ensembl chr 1:142,803,698...142,937,788
|
|
G |
CHRNA9 |
cholinergic receptor nicotinic alpha 9 subunit |
multiple interactions |
EXP |
[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA9 protein; Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA9 protein] |
CTD |
PMID:28235547 |
|
NCBI chr 8:31,430,933...31,456,385
Ensembl chr 8:31,443,043...31,456,384
|
|
G |
CHRNB2 |
cholinergic receptor nicotinic beta 2 subunit |
multiple interactions |
EXP |
[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNB2 protein; Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNB2 protein] |
CTD |
PMID:28235547 |
|
NCBI chr 4:95,196,992...95,211,084
Ensembl chr 4:95,198,717...95,211,037
|
|
|
G |
CAT |
catalase |
multiple interactions |
EXP |
CAT protein inhibits the reaction [[Hypoxanthine co-treated with XDH protein] results in increased chemical synthesis of Carbon Monoxide] |
CTD |
PMID:21984542 |
|
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions |
EXP |
[HMOX1 protein results in increased metabolism of Heme] which results in increased abundance of Carbon Monoxide; chromium mesoporphyrin inhibits the reaction [[HMOX1 protein results in increased metabolism of Heme] which results in increased abundance of Carbon Monoxide]; tin protoporphyrin IX inhibits the reaction [[HMOX1 protein results in increased metabolism of Heme] which results in increased abundance of Carbon Monoxide] |
CTD |
PMID:16751286 |
|
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
multiple interactions |
EXP |
NFKBIA protein inhibits the reaction [Carbon Monoxide results in decreased susceptibility to TNF protein] |
CTD |
PMID:11880364 |
|
NCBI chr 7:64,508,119...64,510,754
Ensembl chr 7:64,507,822...64,511,277
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
EXP |
NFKBIA protein inhibits the reaction [Carbon Monoxide results in decreased susceptibility to TNF protein] |
CTD |
PMID:11880364 |
|
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
|
|
G |
XDH |
xanthine dehydrogenase |
multiple interactions |
EXP |
[Hypoxanthine co-treated with XDH protein] results in increased chemical synthesis of Carbon Monoxide; CAT protein inhibits the reaction [[Hypoxanthine co-treated with XDH protein] results in increased chemical synthesis of Carbon Monoxide]; tempol inhibits the reaction [[Hypoxanthine co-treated with XDH protein] results in increased chemical synthesis of Carbon Monoxide] |
CTD |
PMID:21984542 |
|
NCBI chr 3:107,987,060...108,052,043
Ensembl chr 3:107,987,126...108,053,169
|
|
|
G |
ABCB1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
affects expression |
EXP |
flunixin meglumine affects the expression of ABCB1 mRNA |
CTD |
PMID:26366864 |
|
NCBI chr 9:93,049,955...93,146,469
|
|
G |
CYP1A2 |
cytochrome P450 family 1 subfamily A member 2 |
affects expression |
EXP |
flunixin meglumine affects the expression of CYP1A2 mRNA |
CTD |
PMID:26366864 |
|
NCBI chr 7:58,779,529...58,786,155
Ensembl chr 7:58,779,475...58,786,100
|
|
G |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
affects expression |
EXP |
flunixin meglumine affects the expression of CYP2E1 mRNA |
CTD |
PMID:26366864 |
|
NCBI chr14:141,690,737...141,703,078
Ensembl chr14:141,690,426...141,736,817
|
|
G |
CYP3A22 |
cytochrome P450 family 3 subfamily A member 22 |
affects expression |
EXP |
flunixin meglumine affects the expression of CYP3A22 mRNA |
CTD |
PMID:26366864 |
|
NCBI chr 3:6,617,256...6,665,179
Ensembl chr 3:6,615,343...6,822,817
|
|
G |
CYP3A29 |
cytochrome P450 family 3 subfamily A member 29 |
affects expression |
EXP |
flunixin meglumine affects the expression of CYP3A29 mRNA |
CTD |
PMID:26366864 |
|
NCBI chr 3:6,738,502...6,778,121
Ensembl chr 3:6,738,486...6,778,944
|
|
G |
LOC110262013 |
sulfotransferase 1 family member D1 |
affects expression |
EXP |
flunixin meglumine affects the expression of SULT1A1 mRNA |
CTD |
PMID:26366864 |
|
NCBI chr 8:66,762,885...66,789,582
|
|
|
G |
ALDH7A1 |
aldehyde dehydrogenase 7 family member A1 |
decreases activity multiple interactions |
EXP |
Hydrogen Peroxide results in decreased activity of ALDH7A1 protein Dithiothreitol inhibits the reaction [Hydrogen Peroxide results in decreased activity of ALDH7A1 protein]; Mercaptoethanol inhibits the reaction [Hydrogen Peroxide results in decreased activity of ALDH7A1 protein]; NAD promotes the reaction [Hydrogen Peroxide results in decreased activity of ALDH7A1 protein] |
CTD |
PMID:21296058 |
|
NCBI chr 2:129,663,226...129,709,728
Ensembl chr 2:129,662,969...129,709,705
|
|
G |
CASP3 |
caspase 3 |
multiple interactions increases activity |
EXP |
Sodium Selenite inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP3 protein] |
CTD |
PMID:15191356 |
|
NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213
|
|
G |
CAT |
catalase |
decreases response to substance multiple interactions |
EXP |
CAT results in decreased susceptibility to Hydrogen Peroxide CAT protein inhibits the reaction [Paraquat results in increased abundance of Hydrogen Peroxide] |
CTD |
PMID:11039594 PMID:18086661 |
|
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
increases expression |
EXP |
Hydrogen Peroxide results in increased expression of CXCL8 mRNA |
CTD |
PMID:22083491 |
|
NCBI chr 8:69,932,646...69,935,861
Ensembl chr 8:69,932,643...69,935,861
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
EXP |
Hydrogen Peroxide results in increased expression of FOS mRNA |
CTD |
PMID:18086661 |
|
NCBI chr 7:98,449,508...98,451,971
Ensembl chr 7:98,449,349...98,455,554
|
|
G |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
increases expression multiple interactions |
EXP |
Hydrogen Peroxide results in increased expression of HSPA5 protein Aspirin inhibits the reaction [Hydrogen Peroxide results in increased expression of HSPA5 protein]; nimesulide inhibits the reaction [Hydrogen Peroxide results in increased expression of HSPA5 protein] |
CTD |
PMID:20665602 |
|
NCBI chr 1:265,930,044...265,934,959
Ensembl chr 1:265,930,045...265,934,894
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions increases phosphorylation |
EXP |
3,4-dihydroxyphenylethanol inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:11325585 PMID:21798251 |
|
NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
increases phosphorylation multiple interactions |
EXP |
Hydrogen Peroxide results in increased phosphorylation of MAPK3 protein 3,4-dihydroxyphenylethanol inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:11325585 PMID:21798251 |
|
NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
increases phosphorylation |
EXP |
Hydrogen Peroxide results in increased phosphorylation of MAPK8 protein |
CTD |
PMID:11325585 PMID:18086661 |
|
NCBI chr14:88,988,914...89,108,875
Ensembl chr14:88,988,949...89,108,874
|
|
G |
MAPK9 |
mitogen-activated protein kinase 9 |
increases phosphorylation |
EXP |
Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein |
CTD |
PMID:11325585 |
|
NCBI chr 2:78,338,466...78,399,108
Ensembl chr 2:78,338,376...78,399,100
|
|
G |
SOD1 |
superoxide dismutase 1 |
multiple interactions |
EXP |
[sodium arsenite results in increased activity of SOD1 protein] which results in increased abundance of Hydrogen Peroxide |
CTD |
PMID:12530527 |
|
NCBI chr13:195,326,573...195,335,273
Ensembl chr13:195,326,649...195,337,729
|
|
G |
TNF |
tumor necrosis factor |
increases expression |
EXP |
Hydrogen Peroxide results in increased expression of TNF mRNA |
CTD |
PMID:22083491 |
|
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
|
|
G |
XDH |
xanthine dehydrogenase |
multiple interactions |
EXP |
[Hypoxanthine co-treated with XDH protein] results in increased chemical synthesis of Hydrogen Peroxide |
CTD |
PMID:21984542 |
|
NCBI chr 3:107,987,060...108,052,043
Ensembl chr 3:107,987,126...108,053,169
|
|
|
G |
ACACA |
acetyl-CoA carboxylase alpha |
increases expression multiple interactions |
EXP |
Sodium Glutamate results in increased expression of ACACA mRNA Dietary Fats inhibits the reaction [Sodium Glutamate results in increased expression of ACACA mRNA] |
CTD |
PMID:31360149 |
|
NCBI chr12:38,580,916...38,875,067
Ensembl chr12:38,581,457...38,824,712
|
|
G |
ACOX1 |
acyl-CoA oxidase 1 |
increases expression |
EXP |
Sodium Glutamate results in increased expression of ACOX1 mRNA |
CTD |
PMID:31360149 |
|
NCBI chr12:5,450,913...5,479,550
Ensembl chr12:5,439,361...5,479,546
|
|
G |
FASN |
fatty acid synthase |
multiple interactions increases expression |
EXP |
Dietary Fats inhibits the reaction [Sodium Glutamate results in increased expression of FASN mRNA] |
CTD |
PMID:31360149 |
|
NCBI chr12:922,405...937,560
Ensembl chr12:920,509...937,561
|
|
G |
FFAR1 |
free fatty acid receptor 1 |
affects expression |
EXP |
Sodium Glutamate affects the expression of FFAR1 mRNA |
CTD |
PMID:31360149 |
|
NCBI chr 6:44,837,764...44,841,518
|
|
G |
FFAR2 |
free fatty acid receptor 2 |
multiple interactions affects expression |
EXP |
Dietary Fats affects the reaction [Sodium Glutamate affects the expression of FFAR2 mRNA]; Sodium Glutamate affects the reaction [Dietary Fats affects the expression of FFAR2 mRNA] |
CTD |
PMID:31360149 |
|
NCBI chr 6:44,899,879...44,904,461
Ensembl chr 6:44,901,159...44,904,459
|
|
G |
FFAR4 |
free fatty acid receptor 4 |
affects expression multiple interactions |
EXP |
Sodium Glutamate affects the expression of FFAR4 mRNA Dietary Fats affects the reaction [Sodium Glutamate affects the expression of FFAR4 mRNA]; Sodium Glutamate affects the reaction [Dietary Fats affects the expression of FFAR4 mRNA] |
CTD |
PMID:31360149 |
|
Ensembl chr14:105,011,942...105,037,498
|
|
G |
GPR119 |
G protein-coupled receptor 119 |
affects expression multiple interactions |
EXP |
Sodium Glutamate affects the expression of GPR119 mRNA Dietary Fats affects the reaction [Sodium Glutamate affects the expression of GPR119 mRNA]; Sodium Glutamate affects the reaction [Dietary Fats affects the expression of GPR119 mRNA] |
CTD |
PMID:31360149 |
|
NCBI chr X:106,872,225...106,873,299
Ensembl chr X:106,872,225...106,873,299
|
|
G |
LOC110255234 |
liver carboxylesterase-like |
multiple interactions |
EXP |
Sodium Glutamate inhibits the reaction [Dietary Fats results in decreased expression of CES1 mRNA] |
CTD |
PMID:31360149 |
|
|
|
G |
PNPLA2 |
patatin like phospholipase domain containing 2 |
increases expression |
EXP |
Sodium Glutamate results in increased expression of PNPLA2 mRNA |
CTD |
PMID:31360149 |
|
NCBI chr 2:513,065...517,962
Ensembl chr 2:513,077...518,182
|
|
G |
SREBF1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions increases expression |
EXP |
Dietary Fats inhibits the reaction [Sodium Glutamate results in increased expression of SREBF1 mRNA] |
CTD |
PMID:31360149 |
|
NCBI chr12:60,733,967...60,750,951
Ensembl chr12:60,733,907...60,751,267
|
|
|
G |
ACE |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
multiple interactions |
EXP |
ACE protein inhibits the reaction [KNG1 protein results in increased abundance of Nitric Oxide] |
CTD |
PMID:12672649 |
|
NCBI chr12:15,394,487...15,414,609
Ensembl chr12:15,394,487...15,414,703
|
|
G |
AGT |
angiotensinogen |
affects activity |
EXP |
Nitric Oxide affects the activity of AGT protein |
CTD |
PMID:21127344 |
|
NCBI chr14:59,643,030...59,656,835
Ensembl chr14:59,643,292...59,656,833
|
|
G |
CAPN1 |
calpain 1 |
decreases expression |
EXP |
Nitric Oxide results in decreased expression of CAPN1 mRNA |
CTD |
PMID:9728040 |
|
NCBI chr 2:6,997,513...7,024,410
Ensembl chr 2:6,997,985...7,022,684
|
|
G |
EDN1 |
endothelin 1 |
increases abundance multiple interactions |
EXP |
EDN1 protein results in increased abundance of Nitric Oxide Nitric Oxide deficiency inhibits the reaction [Clofibrate results in decreased expression of EDN1 protein] |
CTD |
PMID:12672649 PMID:17105827 |
|
NCBI chr 7:8,752,018...8,758,354
Ensembl chr 7:8,751,695...8,758,348
|
|
G |
KDSR |
3-ketodihydrosphingosine reductase |
multiple interactions |
EXP |
Nitric Oxide results in increased phosphorylation of and results in decreased activity of BCL2 protein |
CTD |
PMID:16039061 |
|
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,337,522...158,518,879
|
|
G |
KNG1 |
kininogen 1 |
multiple interactions increases abundance |
EXP |
ACE protein inhibits the reaction [KNG1 protein results in increased abundance of Nitric Oxide] |
CTD |
PMID:12672649 |
|
NCBI chr13:124,521,276...124,557,384
Ensembl chr13:124,521,340...124,557,958
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
EXP |
Resveratrol inhibits the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide] |
CTD |
PMID:20825639 |
|
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
|
|
G |
NOS3 |
nitric oxide synthase 3 |
multiple interactions decreases activity |
EXP |
TXNRD1 protein inhibits the reaction [Nitric Oxide results in decreased activity of NOS3 protein] |
CTD |
PMID:8810647 PMID:10823391 |
|
NCBI chr18:6,209,218...6,228,912
Ensembl chr18:6,209,158...6,228,943
|
|
G |
TAC1 |
tachykinin precursor 1 |
increases abundance |
EXP |
TAC1 protein results in increased abundance of Nitric Oxide |
CTD |
PMID:12672649 |
|
NCBI chr 9:77,197,403...77,206,529
Ensembl chr 9:77,197,536...77,206,523
|
|
G |
TXNRD1 |
thioredoxin reductase 1 |
multiple interactions |
EXP |
TXNRD1 protein inhibits the reaction [Nitric Oxide results in decreased activity of NOS3 protein] |
CTD |
PMID:8810647 |
|
NCBI chr 5:80,170,334...80,213,889
Ensembl chr 5:80,172,260...80,236,219
|
|
|
G |
CAPN1 |
calpain 1 |
decreases expression |
EXP |
Nitrogen Dioxide results in decreased expression of CAPN1 mRNA |
CTD |
PMID:9728040 |
|
NCBI chr 2:6,997,513...7,024,410
Ensembl chr 2:6,997,985...7,022,684
|
|
|
G |
SLC22A5 |
solute carrier family 22 member 5 |
increases uptake |
EXP |
SLC22A5 protein results in increased uptake of Acetylcarnitine |
CTD |
PMID:16826461 |
|
NCBI chr 2:134,660,741...134,847,575
Ensembl chr 2:134,660,808...134,686,219
|
|
|
G |
GAPDH |
glyceraldehyde-3-phosphate dehydrogenase |
decreases activity |
EXP |
potassium chromate(VI) results in decreased activity of GAPDH protein |
CTD |
PMID:26582256 |
|
NCBI chr 5:64,129,678...64,135,194
Ensembl chr 5:64,129,679...64,133,991
|
|
|
G |
COMT |
catechol-O-methyltransferase |
multiple interactions |
EXP |
[S-Adenosylmethionine analog co-treated with COMT protein] results in increased methylation of catechol |
CTD |
PMID:20196537 |
|
NCBI chr14:51,384,729...51,403,997
Ensembl chr14:51,385,738...51,403,998
|
|
|
G |
DAO |
D-amino acid oxidase |
decreases activity |
EXP |
Sodium Benzoate results in decreased activity of DAO protein |
CTD |
PMID:20952482 |
|
NCBI chr14:41,931,549...41,950,628
Ensembl chr14:41,931,541...41,950,633
|
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
decreases expression |
EXP |
sodium bichromate results in decreased expression of AKT1 protein |
CTD |
PMID:12760830 |
|
|
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
multiple interactions |
EXP |
sodium metabisulfite inhibits the reaction [deoxynivalenol results in increased expression of CXCL8 mRNA] |
CTD |
PMID:33817499 |
|
NCBI chr 8:69,932,646...69,935,861
Ensembl chr 8:69,932,643...69,935,861
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
EXP |
sodium metabisulfite inhibits the reaction [deoxynivalenol results in increased expression of IL6 mRNA] |
CTD |
PMID:33817499 |
|
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
|
|
|
G |
GAPDH |
glyceraldehyde-3-phosphate dehydrogenase |
multiple interactions |
EXP |
[Sodium Bicarbonate co-treated with Calcium Chloride] results in increased activity of GAPDH protein |
CTD |
PMID:26582256 |
|
NCBI chr 5:64,129,678...64,135,194
Ensembl chr 5:64,129,679...64,133,991
|
|
|
G |
SLC5A5 |
solute carrier family 5 member 5 |
multiple interactions |
EXP |
sodium perchlorate inhibits the reaction [SLC5A5 protein alternative form results in increased uptake of Sodium Iodide]; sodium perchlorate inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide] |
CTD |
PMID:12586784 |
|
NCBI chr 2:59,869,157...59,885,086
Ensembl chr 2:59,869,155...59,885,266
|
|
G |
TPO |
thyroid peroxidase |
decreases activity |
EXP |
sodium perchlorate results in decreased activity of TPO protein |
CTD |
PMID:23959146 |
|
NCBI chr 3:132,384,677...132,409,750
Ensembl chr 3:132,384,583...132,409,208
|
|
|
G |
RYR1 |
ryanodine receptor 1 |
increases activity |
EXP |
Thymol results in increased activity of RYR1 protein |
CTD |
PMID:17641978 |
|
NCBI chr 6:47,339,759...47,458,457
Ensembl chr 6:47,343,768...47,458,458
|
|